Waters Corporation Stock

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 03:58:42 2024-05-03 pm EDT 5-day change 1st Jan Change
320.6 USD +1.58% Intraday chart for Waters Corporation +2.89% -2.71%
Sales 2024 * 2.98B Sales 2025 * 3.16B Capitalization 18.72B
Net income 2024 * 655M Net income 2025 * 725M EV / Sales 2024 * 6.74 x
Net Debt 2024 * 1.38B Net Debt 2025 * 1.09B EV / Sales 2025 * 6.26 x
P/E ratio 2024 *
28.6 x
P/E ratio 2025 *
25.6 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.11%
1 week+2.34%
Current month+2.12%
1 month-7.11%
3 months-1.61%
6 months+28.59%
Current year-4.15%
More quotes
1 week
307.95
Extreme 307.95
322.44
1 month
288.94
Extreme 288.94
346.54
Current year
288.94
Extreme 288.94
363.80
1 year
231.90
Extreme 231.9
363.80
3 years
231.90
Extreme 231.9
428.22
5 years
154.39
Extreme 154.39
428.22
10 years
93.56
Extreme 93.56
428.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 20-08-31
Director of Finance/CFO 48 21-05-11
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 63 18-08-31
Director/Board Member 67 23-03-26
Director/Board Member 70 06-04-30
More insiders
Date Price Change Volume
24-05-03 320.3 +1.50% 331 874
24-05-02 315.6 -0.11% 428,430
24-05-01 315.9 +2.23% 493,908
24-04-30 309 -1.92% 370,283
24-04-29 315.1 +1.22% 313,991

Delayed Quote Nyse, May 02, 2024 at 04:00 pm EDT

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
315.6 USD
Average target price
324.8 USD
Spread / Average Target
+2.93%
Consensus